retatrutide weekly dosage Dosing Guide: 1-12 mg Triple Agonist (2026) Retatrutide dosage chart for weight

Ultimately, the integrity of your research is a chain of custody

Like other GLP-1 drugs, weight regain after stopping is expected

A meta-analysis of 45 trials (94,063 participants), including people with type 2 diabetes enrolled in CVOTs, did not reveal an imbalance between use of GLP-1RA and the incidence of benign or malignant thyroid disease [163]

doi: 10.3892/IJMM.2025.5515 Summary Keywords glucagon-like peptide-1, type 2 diabetes, endothelial function, obesity, metabolic syndrome Citation Hammad BF, Zafar N, Ullah M, Faisal SJ, Iftikhar F, Waheed H, Muzaffar MW, Ahmed K, Ashraf F, Zahid K, Akhtar M and Mahmmoud Fadelallah Eljack M (2025) Exploring the multifaceted roles of GLP-1 receptor agonists